Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ANVS on NYSE
Shares outstanding
19,607,843
Price per share
$3.46
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,024,516
Total reported value
$4,189,706
% of total 13F portfolios
0%
Share change
+212,639
Value change
+$428,194
Number of holders
42
Price from insider filings
$3.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 4.9% -4% $1,470,000 1,000,000 0% CVI Investments, Inc. 31 Mar 2025

As of 30 Sep 2025, 42 institutional investors reported holding 2,024,516 shares of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS). This represents 10% of the company’s total 19,607,843 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) together control 10% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 3.8% 738,003 +5.9% 0% $1,527,667
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.1% 218,421 +33% 0% $452,131
GEODE CAPITAL MANAGEMENT, LLC 0.94% 184,154 +0.47% 0% $381,283
CITADEL ADVISORS LLC 0.89% 174,345 +495% 0% $360,894
NORTHERN TRUST CORP 0.62% 121,060 +103% 0% $250,594
Merit Financial Group, LLC 0.41% 81,316 -11% 0% $168,324
BlackRock, Inc. 0.41% 80,675 0% 0% $166,997
Greenwich Wealth Management LLC 0.24% 47,400 +0.85% 0% $98,000
Wescott Financial Advisory Group, LLC 0.21% 41,607 0% 0.01% $86,126
STATE STREET CORP 0.2% 38,435 0% 0% $79,560
HRT FINANCIAL LP 0.19% 37,579 +258% 0% $77,000
GROUP ONE TRADING LLC 0.18% 34,627 +9.3% 0% $71,678
Lokken Investment Group LLC 0.15% 29,248 +0.04% 0.02% $60,543
XTX Topco Ltd 0.15% 28,854 0% $59,728
Sterling Investment Advisors, Ltd. 0.12% 23,416 0% 0.01% $48,471
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.1% 19,400 0% 0% $40,158
Bank of New York Mellon Corp 0.1% 19,058 0% 0% $39,450
First National Trust Co 0.08% 15,000 0% 0% $31,050
JPMORGAN CHASE & CO 0.08% 14,900 0% 0% $30,843
CWA Asset Management Group, LLC 0.07% 13,001 -32% 0% $26,912
TWO SIGMA SECURITIES, LLC 0.05% 10,511 0% $21,758
Wealthspire Advisors, LLC 0.05% 10,000 0% 0% $20,700
WELLS FARGO & COMPANY/MN 0.05% 9,746 0% 0% $20,174
Wilmington Savings Fund Society, FSB 0.05% 9,393 0% 0% $19,444
MORGAN STANLEY 0.04% 7,389 -39% 0% $15,295

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 46,201 $158,935 +$104,492 $3.46 4
2025 Q3 2,024,516 $4,189,706 +$428,194 $2.07 42
2025 Q2 1,811,877 $3,929,691 -$326,377 $2.17 42
2025 Q1 2,086,860 $3,130,127 -$507,485 $1.50 43
2024 Q4 1,575,712 $7,926,263 +$1,704,856 $5.03 40
2024 Q3 1,179,026 $9,503,457 +$1,923,073 $8.06 35
2024 Q2 984,218 $5,669,358 -$2,073,596 $5.76 29
2024 Q1 1,190,821 $14,170,568 -$404,974 $11.90 29
2023 Q4 1,204,452 $22,522,950 +$2,419,829 $18.70 35
2023 Q3 1,111,889 $10,551,231 -$1,631,804 $9.49 28
2023 Q2 1,278,556 $18,270,029 +$7,489,629 $14.29 27
2023 Q1 752,202 $11,588,203 +$250,861 $15.41 22
2022 Q4 736,307 $9,887,632 +$230,554 $13.43 21
2022 Q3 718,857 $9,847,000 -$399,073 $13.70 20
2022 Q2 770,387 $8,735,000 -$1,477,097 $11.33 24
2022 Q1 888,924 $11,867,000 -$3,780,511 $13.35 22
2021 Q4 1,115,969 $19,619,000 -$2,600,801 $17.58 29
2021 Q3 1,140,634 $36,227,000 -$24,730,573 $31.74 36
2021 Q2 1,272,982 $108,947,000 +$39,294,497 $85.59 56
2021 Q1 834,363 $23,108,000 +$2,874,108 $27.90 29
2020 Q4 759,911 $5,730,000 +$93,763 $7.55 12
2020 Q3 315,551 $1,518,000 +$388,364 $4.81 11
2020 Q2 243,843 $1,060,000 +$220,698 $4.35 8
2020 Q1 192,761 $580,000 +$580,000 $3.01 6